COVID-19 has shown that a commitment to breakthrough innovation, directed allocation of resources, and collaborative approaches can accelerate how scientific breakthroughs can be transitioned to treatments and cures.
Patrick Leahy: “COVID-19 has shown that a commitment to breakthrough innovation, directed allocation of resources, and collaborative…”
On the recordMay 25, 2021
Source
congress.govEditor's note · Context
Leahy highlights COVID-19's impact on accelerating medical innovation.
Share
More from Patrick Leahy
Mar 22, 2023
Congress was the original classification authority (OCA). It let that power essentially slip away to the Executive Branch.
Dec 13, 2022
in 1988, after speaking with Bobby Muller, a Vietnam veteran who was wounded and later founded the Vietnam Veterans of America Foundation--VVAF--to help alleviate the suffering of Vietnamese and Cambodians who were badly injured in the…
Sep 15, 2022
on May 19, I echoed Secretary of State Blinken's call for an ``independent, credible investigation'' of the violent death of widely respected Palestinian-American journalist Shireen Abu Akleh. At that time, several Members of Congress…





